Induct AS (OSL:INDCT)

Norway · Delayed Price · Currency is NOK

1.840

-0.010 (-0.54%)

At close: Jun 3, 2026

Induct AS Earnings Call Transcripts

Fiscal Year 2025

Investor Update
Significant cost reductions and a strategic focus on core healthcare solutions have positioned the company for operational cash positivity in 2025. The collaboration with AstraZeneca and Portsmouth targets rapid scaling of a high-margin asthma care pathway, with strong clinical and financial potential.

Read full transcript →

Slides

Powered by